FDA Warns Tofacitinib (XELJANZ, XELJANZ XR) Increases Risk of Serious Heart-Related Adverse Effects and Cancer

Worst Pills, Best Pills

An expert, independent second opinion on more than 1,800 prescription drugs, over-the-counter medications, and supplements

Print Friendly

All E-Alerts

E-Alerts

Risk of Serious Harm from Sodium Phosphate Products for Constipation (January 13, 2014)
Do Not Use Weight-Loss Dietary Supplement Labeled as OxyElite Pro (October 17, 2013)
Do not use ketoconazole tablets* (October 14, 2013)
Painkiller patches cause accidental deaths in children (September 25, 2013)
Osteoporosis Drug Linked to Rare Bone Cancer (September 24, 2013)
Acetaminophen Causes Rare Skin Disease (August 2, 2013)
FDA warning: Olmesartan can cause serious intestinal problems (July 8, 2013)
FDA Warning: Magnesium Sulfate Poses Risks to Pregnant Women (June 19, 2013)
FDA warns of seizure medication risks (May 24, 2013)
Valproate drugs pose risks for pregnant women and women of childbearing age (May 16, 2013)

4 of 10

The information on this website is not intended to substitute for professional medical advice, diagnosis, or treatment. Consult your doctor before changing or discontinuing any medication.

All E-Alerts

Site Links

Subscriptions

Disclaimer